Mechanism-based combination therapies for metastatic cancer

Sci Transl Med. 2022 Jul 27;14(655):eadd0887. doi: 10.1126/scitranslmed.add0887. Epub 2022 Jul 27.

Author

Anna C Obenauf¹

Affiliation

¹ Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria. Email: anna.obenauf@imp.ac.at.

PMID: 35895833
DOI: 10.1126/scitranslmed.add0887

Abstract

Functional interrogation of cancer and immune cells during tumor evolution reveals cancer drivers and informs mechanism-based combination therapies.

Publication types

Review
Research Support, Non-U.S. Gov't

MeSH terms

Combined Modality Therapy
Humans
Neoplasms* / therapy